Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM GANC MGAM2	2.98e-07	5	63	3	GO:0004558
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	HYAL4 MGAM GANC HYAL1 MANEAL MGAM2	8.71e-07	103	63	6	GO:0004553
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM GANC MGAM2	1.04e-06	7	63	3	GO:0090599
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	HYAL4 MGAM GANC HYAL1 MANEAL MGAM2	6.14e-06	144	63	6	GO:0016798
GeneOntologyMolecularFunction	chondroitin hydrolase activity	HYAL4 HYAL1	9.80e-06	2	63	2	GO:0052757
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM MGAM2	9.80e-06	2	63	2	GO:0004339
GeneOntologyMolecularFunction	endogalactosaminidase activity	HYAL4 HYAL1	9.80e-06	2	63	2	GO:0033931
GeneOntologyMolecularFunction	glucosidase activity	MGAM GANC MGAM2	1.33e-05	15	63	3	GO:0015926
GeneOntologyMolecularFunction	structural constituent of eye lens	CRYBA2 CRYBB2 CRYGS	5.78e-05	24	63	3	GO:0005212
GeneOntologyMolecularFunction	hyalurononglucosaminidase activity	HYAL4 HYAL1	3.48e-04	9	63	2	GO:0004415
GeneOntologyMolecularFunction	metallopeptidase activity	CPXM2 CLCA2 MIPEP MMP27 MMP11	4.21e-04	200	63	5	GO:0008237
GeneOntologyMolecularFunction	carbohydrate binding	MGAM GANC P3H2 SIGLEC14 SIGLEC5 MGAM2	4.31e-04	310	63	6	GO:0030246
GeneOntologyMolecularFunction	metalloendopeptidase activity	CLCA2 MIPEP MMP27 MMP11	5.62e-04	120	63	4	GO:0004222
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	LILRA3 LILRA5	6.34e-04	12	63	2	GO:0032396
GeneOntologyMolecularFunction	hexosaminidase activity	HYAL4 HYAL1	1.29e-03	17	63	2	GO:0015929
GeneOntologyMolecularFunction	MHC class I receptor activity	LILRA3 LILRA5	1.45e-03	18	63	2	GO:0032393
GeneOntologyMolecularFunction	sialic acid binding	SIGLEC14 SIGLEC5	2.80e-03	25	63	2	GO:0033691
GeneOntologyMolecularFunction	monosaccharide binding	P3H2 SIGLEC14 SIGLEC5	3.37e-03	95	63	3	GO:0048029
GeneOntologyBiologicalProcess	maltose metabolic process	MGAM GANC	2.84e-05	3	64	2	GO:0000023
GeneOntologyBiologicalProcess	endoplasmic reticulum tubular network organization	ATL3 ATL2 ATL1	4.21e-05	22	64	3	GO:0071786
GeneOntologyBiologicalProcess	endoplasmic reticulum tubular network membrane organization	ATL2 ATL1	5.66e-05	4	64	2	GO:1990809
GeneOntologyBiologicalProcess	chondroitin sulfate metabolic process	HYAL4 HYAL1 DSE	9.83e-05	29	64	3	GO:0030204
GeneOntologyBiologicalProcess	chondroitin sulfate catabolic process	HYAL4 HYAL1	1.41e-04	6	64	2	GO:0030207
GeneOntologyBiologicalProcess	chondroitin sulfate proteoglycan metabolic process	HYAL4 HYAL1 DSE	1.74e-04	35	64	3	GO:0050654
GeneOntologyCellularComponent	endoplasmic reticulum tubular network membrane	ATL3 ATL2 ATL1	2.47e-07	5	62	3	GO:0098826
GeneOntologyCellularComponent	ficolin-1-rich granule membrane	MGAM LILRA3 SIGLEC14 SIGLEC5	3.23e-05	61	62	4	GO:0101003
GeneOntologyCellularComponent	tertiary granule membrane	MGAM LILRA3 SIGLEC14 SIGLEC5	6.55e-05	73	62	4	GO:0070821
GeneOntologyCellularComponent	endoplasmic reticulum tubular network	ATL3 ATL2 ATL1	1.05e-04	31	62	3	GO:0071782
GeneOntologyCellularComponent	tertiary granule	MGAM LILRA3 OLFM4 SIGLEC14 SIGLEC5	1.26e-04	164	62	5	GO:0070820
GeneOntologyCellularComponent	secretory granule membrane	MGAM LILRA3 ABCA13 VNN1 SIGLEC14 SIGLEC5	4.25e-04	329	62	6	GO:0030667
GeneOntologyCellularComponent	lysosome	HYAL4 TPCN2 MYO5A ABCA13 VNN1 HYAL1 OLFM4 SIGLEC14 SIGLEC5	6.11e-04	811	62	9	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	HYAL4 TPCN2 MYO5A ABCA13 VNN1 HYAL1 OLFM4 SIGLEC14 SIGLEC5	6.11e-04	811	62	9	GO:0000323
GeneOntologyCellularComponent	secretory vesicle	SLC6A7 MGAM LILRA3 MYO5A ABCA13 VNN1 OLFM4 SIGLEC14 SIGLEC5 SLC40A1 MYO5C	9.89e-04	1246	62	11	GO:0099503
GeneOntologyCellularComponent	vacuole	HYAL4 TPCN2 MYO5A ABCA13 VNN1 HYAL1 OLFM4 SIGLEC14 SIGLEC5	1.41e-03	913	62	9	GO:0005773
GeneOntologyCellularComponent	ficolin-1-rich granule	MGAM LILRA3 SIGLEC14 SIGLEC5	2.22e-03	185	62	4	GO:0101002
GeneOntologyCellularComponent	secretory granule	MGAM LILRA3 MYO5A ABCA13 VNN1 OLFM4 SIGLEC14 SIGLEC5 MYO5C	2.88e-03	1014	62	9	GO:0030141
GeneOntologyCellularComponent	extracellular matrix	RELN ANGPTL2 P3H2 MMP27 PAPLN MMP11 USH2A	3.20e-03	656	62	7	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	RELN ANGPTL2 P3H2 MMP27 PAPLN MMP11 USH2A	3.25e-03	658	62	7	GO:0030312
MousePheno	total cataract	CRYBA2 CRYBB2 CRYGS	1.28e-05	13	51	3	MP:0010263
MousePheno	reversion by viral sequence excision	MYO5A AXIN1	1.31e-05	2	51	2	MP:0003176
MousePheno	abnormal eosinophil differentiation	SIGLEC14 SIGLEC5	7.79e-05	4	51	2	MP:0002443
Domain	Glyco_hydro_31_AS	MGAM GANC MGAM2	7.26e-07	6	63	3	IPR030458
Domain	Glycoside_hydrolase_SF	HYAL4 MGAM GANC HYAL1 MGAM2	9.41e-07	53	63	5	IPR017853
Domain	Glyco_hydro_31	MGAM GANC MGAM2	1.27e-06	7	63	3	IPR000322
Domain	Glyco_hydro_31	MGAM GANC MGAM2	1.27e-06	7	63	3	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	MGAM GANC MGAM2	1.27e-06	7	63	3	PS00129
Domain	GBP_C	ATL3 ATL2 ATL1	4.32e-06	10	63	3	PF02841
Domain	G_GB1_RHD3_dom	ATL3 ATL2 ATL1	5.92e-06	11	63	3	IPR030386
Domain	Guanylate-bd_C	ATL3 ATL2 ATL1	5.92e-06	11	63	3	IPR003191
Domain	GBP	ATL3 ATL2 ATL1	5.92e-06	11	63	3	PF02263
Domain	Guanylate-bd_N	ATL3 ATL2 ATL1	5.92e-06	11	63	3	IPR015894
Domain	G_GB1_RHD3	ATL3 ATL2 ATL1	5.92e-06	11	63	3	PS51715
Domain	CRYSTALLIN_BETA_GAMMA	CRYBA2 CRYBB2 CRYGS	1.62e-05	15	63	3	PS50915
Domain	Crystall	CRYBA2 CRYBB2 CRYGS	1.62e-05	15	63	3	PF00030
Domain	Beta/gamma_crystallin	CRYBA2 CRYBB2 CRYGS	1.62e-05	15	63	3	IPR001064
Domain	XTALbg	CRYBA2 CRYBB2 CRYGS	1.62e-05	15	63	3	SM00247
Domain	Gal_mutarotase_SF_dom	MGAM GANC MGAM2	2.40e-05	17	63	3	IPR011013
Domain	G_crystallin-rel	CRYBA2 CRYBB2 CRYGS	2.88e-05	18	63	3	IPR011024
Domain	Tox-GHH_dom	TENM4 TENM1	6.69e-05	4	63	2	IPR028916
Domain	Ten_N	TENM4 TENM1	6.69e-05	4	63	2	IPR009471
Domain	Ten_N	TENM4 TENM1	6.69e-05	4	63	2	PF06484
Domain	TENEURIN_N	TENM4 TENM1	6.69e-05	4	63	2	PS51361
Domain	NtCtMGAM_N	MGAM MGAM2	6.69e-05	4	63	2	PF16863
Domain	Gal_mutarotase_N	MGAM MGAM2	6.69e-05	4	63	2	IPR031727
Domain	Tox-GHH	TENM4 TENM1	6.69e-05	4	63	2	PF15636
Domain	Hyaluronidase	HYAL4 HYAL1	1.11e-04	5	63	2	IPR018155
Domain	Glyco_hydro_56	HYAL4 HYAL1	1.11e-04	5	63	2	PF01630
Domain	Myosin_S1_N	MYO5A MYO5C	1.11e-04	5	63	2	IPR008989
Domain	-	C11orf68 EIF4E2	1.11e-04	5	63	2	3.30.760.10
Domain	YD	TENM4 TENM1	1.11e-04	5	63	2	IPR006530
Domain	TIF_eIF_4E	C11orf68 EIF4E2	1.11e-04	5	63	2	IPR001040
Domain	TIF_eIF4e-like	C11orf68 EIF4E2	1.11e-04	5	63	2	IPR023398
Domain	DIL	MYO5A MYO5C	1.67e-04	6	63	2	PF01843
Domain	Dilute_dom	MYO5A MYO5C	1.67e-04	6	63	2	IPR002710
Domain	DILUTE	MYO5A MYO5C	1.67e-04	6	63	2	PS51126
Domain	DIL	MYO5A MYO5C	1.67e-04	6	63	2	SM01132
Domain	EGF_1	HYAL4 RELN TENM4 HYAL1 TENM1 USH2A	2.16e-04	255	63	6	PS00022
Domain	Trefoil	MGAM MGAM2	3.09e-04	8	63	2	PF00088
Domain	P_TREFOIL_2	MGAM MGAM2	3.97e-04	9	63	2	PS51448
Domain	PD	MGAM MGAM2	3.97e-04	9	63	2	SM00018
Domain	-	MGAM MGAM2	6.04e-04	11	63	2	4.10.110.10
Domain	P_trefoil_dom	MGAM MGAM2	7.23e-04	12	63	2	IPR000519
Domain	NCD3G	TAS1R2 GRM2	8.53e-04	13	63	2	PF07562
Domain	GPCR_3_9-Cys_dom	TAS1R2 GRM2	8.53e-04	13	63	2	IPR011500
Domain	NHL	TENM4 TENM1	8.53e-04	13	63	2	PS51125
Domain	GPCR_3_CS	TAS1R2 GRM2	9.93e-04	14	63	2	IPR017979
Domain	EGF_extracell	RELN TENM4 TENM1	1.09e-03	60	63	3	IPR013111
Domain	EGF_2	RELN TENM4 TENM1	1.09e-03	60	63	3	PF07974
Domain	Pept_M10A_Zn_BS	MMP27 MMP11	1.14e-03	15	63	2	IPR021158
Domain	IGc2	LILRA3 SIGLEC14 SIGLEC5 PAPLN LILRA5	1.17e-03	235	63	5	SM00408
Domain	Ig_sub2	LILRA3 SIGLEC14 SIGLEC5 PAPLN LILRA5	1.17e-03	235	63	5	IPR003598
Domain	EGF	HYAL4 RELN TENM4 HYAL1 TENM1	1.17e-03	235	63	5	SM00181
Domain	Hemopexin_CS	MMP27 MMP11	1.47e-03	17	63	2	IPR018486
Domain	CarboxyPept-like_regulatory	TENM4 CPXM2	1.47e-03	17	63	2	IPR008969
Domain	Pept_M10A_stromelysin-type	MMP27 MMP11	1.65e-03	18	63	2	IPR016293
Domain	Ig_2	LILRA3 SIGLEC14 LILRA5	1.92e-03	73	63	3	PF13895
Domain	EGF_2	HYAL4 RELN TENM4 HYAL1 TENM1	1.99e-03	265	63	5	PS01186
Domain	GPCR_3	TAS1R2 GRM2	2.26e-03	21	63	2	IPR000337
Domain	7tm_3	TAS1R2 GRM2	2.48e-03	22	63	2	PF00003
Domain	G_PROTEIN_RECEP_F3_2	TAS1R2 GRM2	2.48e-03	22	63	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	TAS1R2 GRM2	2.48e-03	22	63	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	TAS1R2 GRM2	2.48e-03	22	63	2	PS00979
Domain	G_PROTEIN_RECEP_F3_4	TAS1R2 GRM2	2.48e-03	22	63	2	PS50259
Domain	GPCR_3_C	TAS1R2 GRM2	2.48e-03	22	63	2	IPR017978
Domain	MetalloPept_cat_dom	MIPEP MMP27 MMP11	2.59e-03	81	63	3	IPR024079
Domain	-	MIPEP MMP27 MMP11	2.59e-03	81	63	3	3.40.390.10
Domain	Hemopexin-like_dom	MMP27 MMP11	2.71e-03	23	63	2	IPR000585
Domain	Hemopexin-like_repeat	MMP27 MMP11	2.71e-03	23	63	2	IPR018487
Domain	M10A_MMP	MMP27 MMP11	2.71e-03	23	63	2	IPR033739
Domain	Hemopexin	MMP27 MMP11	2.71e-03	23	63	2	PF00045
Domain	HEMOPEXIN	MMP27 MMP11	2.71e-03	23	63	2	PS00024
Domain	-	MMP27 MMP11	2.71e-03	23	63	2	2.110.10.10
Domain	HEMOPEXIN_2	MMP27 MMP11	2.71e-03	23	63	2	PS51642
Domain	HX	MMP27 MMP11	2.71e-03	23	63	2	SM00120
Domain	Pept_M10A	MMP27 MMP11	2.71e-03	23	63	2	IPR021190
Domain	IG	LILRA3 SIGLEC14 SIGLEC5 PAPLN LILRA5 SEMA4G	2.91e-03	421	63	6	SM00409
Domain	Ig_sub	LILRA3 SIGLEC14 SIGLEC5 PAPLN LILRA5 SEMA4G	2.91e-03	421	63	6	IPR003599
Domain	Peptidase_M10	MMP27 MMP11	2.95e-03	24	63	2	PF00413
Domain	ZnMc	MMP27 MMP11	4.29e-03	29	63	2	SM00235
Domain	Peptidase_Metallo	MMP27 MMP11	4.29e-03	29	63	2	IPR006026
Domain	ZINC_PROTEASE	MIPEP MMP27 MMP11	4.43e-03	98	63	3	PS00142
Domain	Znf-RING_LisH	TRIM6 TRIM22	5.86e-03	34	63	2	IPR027370
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_	MGAM GANC MGAM2	2.35e-06	9	44	3	M47622
Pubmed	Human atlastin GTPases mediate differentiated fusion of endoplasmic reticulum membranes.	ATL3 ATL2 ATL1	5.94e-09	3	64	3	25773277
Pubmed	Mammalian knock out cells reveal prominent roles for atlastin GTPases in ER network morphology.	ATL3 ATL2 ATL1	5.94e-09	3	64	3	27669642
Pubmed	Cooperation of the ER-shaping proteins atlastin, lunapark, and reticulons to generate a tubular membrane network.	ATL3 ATL2 ATL1	5.93e-08	5	64	3	27619977
Pubmed	A class of dynamin-like GTPases involved in the generation of the tubular ER network.	ATL3 ATL2 ATL1	2.07e-07	7	64	3	19665976
Pubmed	Protrudin binds atlastins and endoplasmic reticulum-shaping proteins and regulates network formation.	ATL3 ATL2 ATL1	2.07e-07	7	64	3	23969831
Pubmed	The E3 Ubiquitin Ligase SYVN1 Ubiquitinates Atlastins to Remodel the Endoplasmic Reticulum Network.	ATL3 ATL2 ATL1	4.95e-07	9	64	3	32916628
Pubmed	Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions.	CRYBA2 CRYBB2 CRYGS	9.70e-07	11	64	3	10595510
Pubmed	Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.	SIGLEC14 SIGLEC5	3.33e-06	2	64	2	24799499
Pubmed	Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin.	MYO5A MYO5C	3.33e-06	2	64	2	26912658
Pubmed	Reconstitution of human atlastin fusion activity reveals autoinhibition by the C terminus.	ATL2 ATL1	3.33e-06	2	64	2	34817557
Pubmed	Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.	SIGLEC14 SIGLEC5	3.33e-06	2	64	2	26459514
Pubmed	Human myosin-Vc is a novel class V myosin expressed in epithelial cells.	MYO5A MYO5C	3.33e-06	2	64	2	11870218
Pubmed	Atlastin GTPases are required for Golgi apparatus and ER morphogenesis.	ATL3 ATL2	3.33e-06	2	64	2	18270207
Pubmed	Structural insights into the globular tails of the human type v myosins Myo5a, Myo5b, And Myo5c.	MYO5A MYO5C	9.99e-06	3	64	2	24339992
Pubmed	Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	24698729
Pubmed	Atlastin 2/3 regulate ER targeting of the ULK1 complex to initiate autophagy.	ATL3 ATL2	9.99e-06	3	64	2	33988678
Pubmed	Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	11579105
Pubmed	ASB17 Facilitates the Burst of LPS-Induced Inflammation Through Maintaining TRAF6 Stability.	ASB17 NFKBIA	9.99e-06	3	64	2	35174103
Pubmed	Structural insights into functional overlapping and differentiation among myosin V motors.	MYO5A MYO5C	9.99e-06	3	64	2	24097982
Pubmed	Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	17012248
Pubmed	Siglec-F is induced by granulocyte-macrophage colony-stimulating factor and enhances interleukin-4-induced expression of arginase-1 in mouse macrophages.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	31520477
Pubmed	Antiallergic effect of anti-Siglec-F through reduction of eosinophilic inflammation in murine allergic rhinitis.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	23710953
Pubmed	Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	19783675
Pubmed	Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	30577572
Pubmed	Energetics of domain-domain interactions and entropy driven association of beta-crystallins.	CRYBA2 CRYBB2	9.99e-06	3	64	2	14717595
Pubmed	A novel Siglec-F+ neutrophil subset in the mouse nasal mucosa exhibits an activated phenotype and is increased in an allergic rhinitis model.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	32247614
Pubmed	Linkage analysis of the murine Hyal-1 locus on chromosome 9.	MYO5A HYAL1	9.99e-06	3	64	2	2022949
Pubmed	Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	32134149
Pubmed	Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	25497369
Pubmed	Siglec-F is a novel intestinal M cell marker.	SIGLEC14 SIGLEC5	9.99e-06	3	64	2	27524237
Pubmed	Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.	SIGLEC14 SIGLEC5	2.00e-05	4	64	2	17562860
Pubmed	Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.	SIGLEC14 SIGLEC5	2.00e-05	4	64	2	17272508
Pubmed	Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.	SIGLEC14 SIGLEC5	2.00e-05	4	64	2	19178537
Pubmed	TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.	NFKBIA TRIM22	2.00e-05	4	64	2	32814880
Pubmed	Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues.	TENM4 TENM1	2.00e-05	4	64	2	10225957
Pubmed	Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration.	SIGLEC14 SIGLEC5	2.00e-05	4	64	2	33289969
Pubmed	Induction of Siglec-FhiCD101hi eosinophils in the lungs following murine hookworm Nippostrongylus brasiliensis infection.	SIGLEC14 SIGLEC5	2.00e-05	4	64	2	37251384
Pubmed	All four members of the Ten-m/Odz family of transmembrane proteins form dimers.	TENM4 TENM1	2.00e-05	4	64	2	12000766
Pubmed	Imbalances in the eye lens proteome are linked to cataract formation.	CRYBA2 CRYBB2	2.00e-05	4	64	2	33432246
Pubmed	Alternative splicing in class V myosins determines association with Rab10.	MYO5A MYO5C	2.00e-05	4	64	2	19008234
Pubmed	IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils.	SIGLEC14 SIGLEC5	2.00e-05	4	64	2	33976385
Pubmed	Linkage analysis of the Gi alpha 2 gene on mouse chromosome 9.	MYO5A HYAL1	2.00e-05	4	64	2	1421769
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	ANGPTL2 CPXM2 MMP27 OLFM4 SIGLEC14 SIGLEC5 PAPLN	2.19e-05	460	64	7	20562862
Pubmed	Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs.	SIGLEC14 SIGLEC5	3.32e-05	5	64	2	20395633
Pubmed	Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13.	SIGLEC14 SIGLEC5	3.32e-05	5	64	2	21040544
Pubmed	Siglec-F-expressing neutrophils are essential for creating a profibrotic microenvironment in renal fibrosis.	SIGLEC14 SIGLEC5	3.32e-05	5	64	2	35482420
Pubmed	Overlapping effects of different members of the FGF family on lens fiber differentiation in transgenic mice.	CRYBA2 CRYBB2	4.98e-05	6	64	2	9693140
Pubmed	Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue.	SIGLEC14 SIGLEC5	4.98e-05	6	64	2	23880769
Pubmed	Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G).	SIGLEC14 SIGLEC5	4.98e-05	6	64	2	14559209
Pubmed	The beta crystallin genes on human chromosome 22 define a new region of homology with mouse chromosome 5.	CRYBA2 CRYBB2	4.98e-05	6	64	2	7789995
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	HYAL4 CRYBB2 CLCA2 ABCA13 TENM1 EI24 ATL3	6.94e-05	552	64	7	10737800
Pubmed	[Functions and molecular evolution of Siglecs, a family of sialic acid receptor proteins].	SIGLEC14 SIGLEC5	6.96e-05	7	64	2	18453149
Pubmed	Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.	SIGLEC14 SIGLEC5	6.96e-05	7	64	2	23677475
Pubmed	Assignment of the beta B1 crystallin gene (CRYBB1) to human chromosome 22 and mouse chromosome 5.	CRYBA2 CRYBB2	6.96e-05	7	64	2	8575764
Pubmed	The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils.	SIGLEC14 SIGLEC5	6.96e-05	7	64	2	15048729
Pubmed	Unique features of TRIM5alpha among closely related human TRIM family members.	TRIM6 TRIM22	6.96e-05	7	64	2	17156811
Pubmed	The murine Ten-m/Odz genes show distinct but overlapping expression patterns during development and in adult brain.	TENM4 TENM1	6.96e-05	7	64	2	12915301
Pubmed	Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen.	SIGLEC14 SIGLEC5	6.96e-05	7	64	2	23840825
Pubmed	Mapping homologs of Drosophila odd Oz (odz): Doc4/Odz4 to mouse chromosome 7, Odz1 to mouse chromosome 11; and ODZ3 to human chromosome Xq25.	TENM4 TENM1	9.27e-05	8	64	2	10331952
Pubmed	Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens.	CRYBB2 CRYGS	1.19e-04	9	64	2	8999933
Pubmed	The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.	MGAM MYO5C	1.19e-04	9	64	2	25857663
Pubmed	Unipolar brush cells of the cerebellum are produced in the rhombic lip and migrate through developing white matter.	RELN GRM2	1.49e-04	10	64	2	16957075
Pubmed	Cartography of teneurin and latrophilin expression reveals spatiotemporal axis heterogeneity in the mouse hippocampus during development.	TENM4 TENM1	1.49e-04	10	64	2	38713721
Pubmed	The upstream ectoderm enhancer in Pax6 has an important role in lens induction.	CRYBA2 CRYBB2	1.81e-04	11	64	2	11714668
Pubmed	Shotgun identification of protein modifications from protein complexes and lens tissue.	CRYBB2 CRYGS	1.81e-04	11	64	2	12060738
Pubmed	Selective Response to Bacterial Infection by Regulating Siglec-E Expression.	SIGLEC14 SIGLEC5	1.81e-04	11	64	2	32889432
Pubmed	ESYT1 tethers the ER to mitochondria and is required for mitochondrial lipid and calcium homeostasis.	LMF2 ATL3 ATL2 ATL1 STT3B	2.29e-04	299	64	5	37931956
Pubmed	CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.	SIGLEC14 SIGLEC5	2.57e-04	13	64	2	35921817
Pubmed	The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops.	CRYBA2 CRYBB2	2.99e-04	14	64	2	21998302
Pubmed	Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma.	MYO5A NFKBIA	2.99e-04	14	64	2	30542119
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO5A MYO5C	2.99e-04	14	64	2	8022818
Pubmed	Unique contribution of heat shock transcription factor 4 in ocular lens development and fiber cell differentiation.	CRYBA2 CRYBB2	3.93e-04	16	64	2	15593327
Pubmed	Regulation of mouse lens fiber cell development and differentiation by the Maf gene.	CRYBA2 CRYBB2	4.45e-04	17	64	2	10603348
Pubmed	Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization.	SIGLEC14 SIGLEC5	4.45e-04	17	64	2	35709757
Pubmed	Regulation of ocular lens development by Smad-interacting protein 1 involving Foxe3 activation.	CRYBA2 CRYGS	5.00e-04	18	64	2	16162653
Pubmed	TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition.	TRIM6 TRIM22	6.20e-04	20	64	2	25127057
Pubmed	Matrix metalloproteinases.	MMP27 MMP11	7.52e-04	22	64	2	10419448
Pubmed	Functional interactions between matrix metalloproteinases and glycosaminoglycans.	MMP27 MMP11	7.52e-04	22	64	2	23421805
Pubmed	Genome-wide association study of periodontal health measured by probing depth in adults ages 18-49 years.	ATL1 STT3B	8.96e-04	24	64	2	24347629
Pubmed	Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms.	SIGLEC14 SIGLEC5	8.96e-04	24	64	2	15331780
Pubmed	TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage Homeostasis.	TRIM6 TRIM22	8.96e-04	24	64	2	27693506
Pubmed	Stromal β-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.	CPXM2 MMP11	9.73e-04	25	64	2	32541007
Pubmed	Developmental abnormalities in cortical GABAergic system in mice lacking mGlu3 metabotropic glutamate receptors.	RELN GRM2	9.73e-04	25	64	2	31665922
Pubmed	A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells.	HYAL4 USH2A STT3B	9.75e-04	105	64	3	23284306
Pubmed	The transcription factor c-Maf controls touch receptor development and function.	CRYBA2 CRYGS	1.14e-03	27	64	2	22345400
Pubmed	A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting.	SIGLEC14 SIGLEC5	1.31e-03	29	64	2	33567267
Pubmed	TLR sorting by Rab11 endosomes maintains intestinal epithelial-microbial homeostasis.	NFKBIA OLFM4	1.40e-03	30	64	2	25063677
Pubmed	Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.	MYO5A MYO5C	1.50e-03	31	64	2	30642949
Cytoband	15q21	MYO5A MYO5C	1.04e-04	11	64	2	15q21
Cytoband	19q13.4	LILRA3 SIGLEC14 LILRA5	1.89e-04	79	64	3	19q13.4
Cytoband	11q24	EI24 MMP27	2.27e-04	16	64	2	11q24
Cytoband	Ensembl 112 genes in cytogenetic band chr11q13	C2CD3 TPCN2 P2RY2 C11orf68 ATL3	4.37e-04	454	64	5	chr11q13
GeneFamily	Beta-gamma crystallins	CRYBA2 CRYBB2 CRYGS	5.20e-06	15	42	3	1359
GeneFamily	Myosins, class V	MYO5A MYO5C	1.58e-05	3	42	2	1100
GeneFamily	CD molecules\|Activating leukocyte immunoglobulin like receptors	LILRA3 LILRA5	7.86e-05	6	42	2	1181
GeneFamily	Endogenous ligands\|Matrix metallopeptidases	MMP27 MMP11	1.41e-03	24	42	2	891
GeneFamily	CD molecules\|C2-set domain containing\|Sialic acid binding Ig like lectins	SIGLEC14 SIGLEC5	1.92e-03	28	42	2	745
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM6 TRIM22	2.05e-02	95	42	2	59
ToppCell	LPS_only-Myeloid-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5 GAS7	2.26e-07	179	64	6	d0a03e498afcfeb657037889685ecd77bed07e6c
ToppCell	LPS_only-Myeloid-Neutrophils-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5 GAS7	2.26e-07	179	64	6	d034651a5a355a58f5e15db627869f4feebdfe35
ToppCell	LPS-IL1RA-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5 GAS7	2.33e-07	180	64	6	c0c07937839652e01df10cc1e70aa005800ea6f6
ToppCell	LPS-IL1RA-Myeloid-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5 GAS7	2.33e-07	180	64	6	079c199425dd3c220f03c6dca1823946f07580a1
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5 GAS7	2.49e-07	182	64	6	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5 GAS7	2.49e-07	182	64	6	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN TENM4 ABCA13 TENM1 USH2A	2.65e-07	184	64	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN TENM4 ABCA13 TENM1 USH2A	2.65e-07	184	64	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN TENM4 ABCA13 TENM1 USH2A	2.65e-07	184	64	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	wk_15-18-Hematologic-Myeloid-Myelocyte-like\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MGAM ABCA13 VNN1 OLFM4 SIGLEC14 SIGLEC5	2.74e-07	185	64	6	92b9ec18ff7c53a52b87e2c2012d0b719a7ad20a
ToppCell	Control-Myeloid-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 VNN1 OLFM4 SIGLEC5	2.76e-06	153	64	5	c33d63b2d1a220bc428e776b157b23faa43ea8ca
ToppCell	Control-Myeloid-Neutrophils-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 VNN1 OLFM4 SIGLEC5	2.76e-06	153	64	5	e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd
ToppCell	E17.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MYO5A NFKBIA GAS7 SLC40A1	3.88e-06	164	64	5	4e9de41ea10ce3233c09e144bfc0453c0ae79fd3
ToppCell	E17.5-Endothelial-lymphatic_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MYO5A NFKBIA GAS7 SLC40A1	3.88e-06	164	64	5	6f4914b0ac282b4b9f6111930a82515178c1bc80
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 SLC40A1 LILRA5 DSE	4.89e-06	172	64	5	c96bd3407911df3e3e6d7a3dba786b11814b9598
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TENM4 ANGPTL2 C11orf68 MYMK GAS7	5.32e-06	175	64	5	1d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TENM4 ANGPTL2 C11orf68 MYMK GAS7	5.32e-06	175	64	5	427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell	LPS-antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5	5.78e-06	178	64	5	afcc92e8fe313c85eaf617cf4dbc3058da6c99d6
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCHS2 RELN TENM4 P3H2 PAPLN	5.78e-06	178	64	5	544379f5a6145429762258d426b876bb36c112f5
ToppCell	LPS-antiTNF-Myeloid-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA OLFM4 SIGLEC5	5.78e-06	178	64	5	bd689205bc92cda5f71df64c2332ff76adcd84b4
ToppCell	LPS-IL1RA+antiTNF-Myeloid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MGAM LILRA3 NFKBIA SIGLEC5 GAS7	7.35e-06	187	64	5	4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5
ToppCell	cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MGAM VNN1 TENM1 SIGLEC5 LILRA5	7.74e-06	189	64	5	fedab592be1d6520325b8c1b659b0a4dc3f4fe4d
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MGAM ABCA13 VNN1 OLFM4 SLC40A1	8.35e-06	192	64	5	072281344d58e85c9a290750b488d0c101f75d54
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NFKBIA OLFM4 SIGLEC14 SIGLEC5 LILRA5	8.56e-06	193	64	5	891c0d4119a1c090b8230d00f9f69997850cab8c
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MGAM ABCA13 VNN1 OLFM4 LILRA5	9.93e-06	199	64	5	5919933c4b842b98fc98685dc8c72c8dd32c6ea3
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MGAM ABCA13 VNN1 OLFM4 LILRA5	9.93e-06	199	64	5	caf2e050b21e7a16ce4e51b3f135debd06810231
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HYAL4 DCHS2 TENM4 OLFM4	7.70e-05	157	64	4	beab0ac47202266b04543c02cfcdda012375e879
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 SLC40A1 LILRA5	9.34e-05	165	64	4	47e716ce8dc283d406352c1909e09362fcb9e3a3
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 SLC40A1 LILRA5	9.34e-05	165	64	4	fe2135fdacf3807eb4b5ea5e790febfb8cd54335
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRYBA2 MGAM MANEAL USH2A	9.56e-05	166	64	4	afba41e15478053f11815acf568d29187de75492
ToppCell	facs-Lung-Endomucin-24m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBB2 MGAM CRYGS CLCA2	9.56e-05	166	64	4	64a0762eb9cafb6a079df296ed677c8e0ae0efa7
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 SLC40A1 DSE	1.05e-04	170	64	4	6ec0cf055ae55e9fac147f7989c47f83ab07270c
ToppCell	facs-Lung-24m-Epithelial-airway_epithelial-club_cell-club_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBB2 CRYGS CLCA2 SEMA4G	1.07e-04	171	64	4	8ed98f223143bd81d9819e9a420eb9cc81ee6c53
ToppCell	facs-Lung-24m-Epithelial-airway_epithelial-club_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBB2 CRYGS CLCA2 SEMA4G	1.07e-04	171	64	4	bd339e482f09a3fa04b086029b94f45205b8a6c5
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic\|GI_small-bowel / Manually curated celltypes from each tissue	P2RY2 SIGLEC14 GAS7 LILRA5	1.07e-04	171	64	4	098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAM RELN GAS7 ZC3H12C	1.12e-04	173	64	4	922356a5b4c84607318ac24d7caa2e235b72b066
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	P2RY2 SIGLEC14 GAS7 LILRA5	1.15e-04	174	64	4	05d54a36772f096047521e16a89cc42ae48d2a1d
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NFKBIA GAS7 LILRA5 DSE	1.17e-04	175	64	4	cd42020fe57afeaadfbd3ef6d7375e66d71e9669
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 LILRA5 DSE	1.20e-04	176	64	4	adb679e69c0c17f0caee4c141bac55d03c963012
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HYAL4 TSTD1 CRYBA2 MANEAL	1.22e-04	177	64	4	8dbef0005095c01a806d8c7f723dc48a4650efec
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 LILRA5 DSE	1.22e-04	177	64	4	ab92ffc9624850a50c88e6b8f3a517ff2251ff15
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	TENM4 MYO5A SIGLEC5 DSE	1.28e-04	179	64	4	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A GAS7 SLC40A1 LILRA5	1.31e-04	180	64	4	a600bc705993d3a010550a25d3b54358946f061f
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 ANGPTL2 MANEAL SEMA4G	1.36e-04	182	64	4	9edaccf1154cec92ca9a28e9b1f9075cfd422bfd
ToppCell	cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MGAM VNN1 SIGLEC5 LILRA5	1.36e-04	182	64	4	1932d77491d6d46278f01fd70eb469ef1b356619
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 ANGPTL2 MANEAL SEMA4G	1.36e-04	182	64	4	aba4c06d5d7618ac21b2695bca8e7a1346a91090
ToppCell	LPS_only-Myeloid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LILRA3 NFKBIA SIGLEC5 GAS7	1.36e-04	182	64	4	666ac86ee5f6fa9241ae8d80340743707e54b278
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSTD1 VNN1 TENM1 MYO5C	1.39e-04	183	64	4	2df1611c8acccb2a6f233d3d68bd9df2381a7278
ToppCell	cellseq2-Immune-Hematopoietic-Granulocytic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MGAM VNN1 SIGLEC5 LILRA5	1.39e-04	183	64	4	cfbf8539104cef9ca830ad4f6bb278746f7078f7
ToppCell	cellseq2-Immune-Hematopoietic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MGAM VNN1 SIGLEC5 LILRA5	1.39e-04	183	64	4	324ec4374b552da7ce03809945b3a0798342d4ba
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSTD1 TENM4 P3H2 MYO5C	1.39e-04	183	64	4	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ANGPTL2 PAPLN ADCYAP1R1	1.45e-04	185	64	4	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ANGPTL2 PAPLN ADCYAP1R1	1.45e-04	185	64	4	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ANGPTL2 PAPLN ADCYAP1R1	1.45e-04	185	64	4	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	LPS-IL1RA-Myeloid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LILRA3 NFKBIA SIGLEC5 GAS7	1.45e-04	185	64	4	9b5fd87ea9d05e051ff1251578ecfbe5e8652853
ToppCell	wk_20-22-Hematologic-Myeloid-Myelocyte-like\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	VNN1 OLFM4 SIGLEC5 LILRA5	1.48e-04	186	64	4	53b4ce33ae6fa32f1b56cbc62b1d7915e935afc9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM P3H2 TENM1 PAPLN	1.51e-04	187	64	4	dcf6475ece5b34d9d58a0d1f51c18acedb19c119
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM P3H2 TENM1 PAPLN	1.51e-04	187	64	4	f1356273bd3587b6883295edf15cb9cdb706c057
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN TENM1 SIGLEC5 GAS7	1.54e-04	188	64	4	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.54e-04	188	64	4	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.54e-04	188	64	4	3cfba3addcc9058f4ec31ad96261f79988f551a0
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MGAM ABCA13 MMP27 OLFM4	1.57e-04	189	64	4	3b35022c0619df6db234613aa53a076899ca9562
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MGAM ABCA13 MMP27 OLFM4	1.57e-04	189	64	4	358ff514f1c8aa46067208ddf1b68396d789c130
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VNN1 SIGLEC14 LILRA5 DSE	1.61e-04	190	64	4	57800d807785b9d539b47945a0a74631f5e88a06
ToppCell	wk_08-11-Epithelial-PNS-Early_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	RELN TPCN2 PAQR8 GAS7	1.61e-04	190	64	4	8190674a48607984726974765aafbca116f437e0
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 VNN1 MMP27 OLFM4	1.61e-04	190	64	4	896b5825edb30fe62cbbed6078570c1f8057a99e
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SIGLEC14 ZC3H12C LILRA5 DSE	1.64e-04	191	64	4	0b296404ebad0aadb75737f8c0462ec6934fc8bb
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.64e-04	191	64	4	63aa671837b79d2feb7ed1e67712cc01caf72bef
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VNN1 SIGLEC14 LILRA5 DSE	1.64e-04	191	64	4	1c7d31684654ca6a046d8cc816af1fdc42369c57
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VNN1 SIGLEC14 LILRA5 DSE	1.64e-04	191	64	4	d60d81d2045c6e624bbc8b17e13a32f7921d969f
ToppCell	PSB-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NFKBIA SIGLEC14 SIGLEC5 LILRA5	1.67e-04	192	64	4	8dbdaa6a81767a866fb856f99ae35f9ee8064106
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	P2RY2 GAS7 LILRA5 DSE	1.67e-04	192	64	4	f14ee74ac3275601749a23c5efe39c2413a62e1a
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.67e-04	192	64	4	c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TENM1 SEMA4G ADCYAP1R1	1.67e-04	192	64	4	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	P2RY2 GAS7 LILRA5 DSE	1.67e-04	192	64	4	0219093e7921a0db78053aee13ec480b520f5662
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.71e-04	193	64	4	b25cdca3a1e381784ae48ca73c51cbb6ac62b811
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCHS2 ANGPTL2 P3H2 ADCYAP1R1	1.71e-04	193	64	4	7cd9671e0ac64f7f3607f564485c63abbb7e7a63
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.71e-04	193	64	4	b38aaffbea36ef6c08ebe82675438f873c89b242
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	NFKBIA GAS7 LILRA5 DSE	1.71e-04	193	64	4	ddbd8944661ac3b0b5fe63471bdc24ba05598017
ToppCell	Control-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	P2RY2 VNN1 GAS7 LILRA5	1.71e-04	193	64	4	3479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MGAM VNN1 SIGLEC14 LILRA5	1.71e-04	193	64	4	b044fca95f519ff2ceb378afe40a95911931a29e
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VNN1 SIGLEC14 SIGLEC5 LILRA5	1.71e-04	193	64	4	db26b79dfe9c48388f6b64dceb21073d104ab504
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO5A GAS7 SLC40A1 DSE	1.74e-04	194	64	4	48c37251518f96524807b5bd1bbc2820637666ad
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HYAL4 MGAM NFKBIA LILRA5	1.74e-04	194	64	4	4eef50c38e6edb2ef2cdcd14eb50805f6cd65bc8
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO5A GAS7 SLC40A1 DSE	1.74e-04	194	64	4	7b6a34d1f8922b71dcc931421666c1822cec8345
ToppCell	PCW_13-14-Epithelial-Epithelial_airway\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.74e-04	194	64	4	7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO5A GAS7 SLC40A1 DSE	1.74e-04	194	64	4	435406ebe626c702f7d5a99a3d68ee85aa09be95
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.77e-04	195	64	4	d67a2b489c29bfd575751c13d2a5b1efdec5240a
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSTD1 CPXM2 P3H2 MYO5C	1.77e-04	195	64	4	d673f8844896d5c7b76a7bc7f6b88a039f1bc263
ToppCell	343B-Myeloid-Monocyte\|343B / Donor, Lineage, Cell class and subclass (all cells)	NFKBIA SIGLEC14 LILRA5 DSE	1.77e-04	195	64	4	169b4952118ca5ded55de928a1cf08721cdac193
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	P2RY2 VNN1 GAS7 LILRA5	1.77e-04	195	64	4	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRA3 NFKBIA LILRA5 DSE	1.77e-04	195	64	4	d87c83d2d421c9291d0a10bc9db850e9fb337667
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MGAM ABCA13 OLFM4 LILRA5	1.77e-04	195	64	4	fb3dc2c8fd125f23d0c3aa211520778aac8d6dda
ToppCell	mild-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM SIGLEC14 TRIM22 LILRA5	1.81e-04	196	64	4	ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TENM1 SEMA4G ADCYAP1R1	1.81e-04	196	64	4	7af6c5147ac859353504d19727dbe24f63a29dd4
ToppCell	11.5-Distal-Epithelial-Bud_tip_adjacent\|Distal / Age, Tissue, Lineage and Cell class	TSTD1 CPXM2 P3H2 MYO5C	1.81e-04	196	64	4	a6a242868df0d2ff30825624a8d7c0367527594d
ToppCell	mild-Myeloid-Neutrophils_2\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM SIGLEC14 TRIM22 LILRA5	1.81e-04	196	64	4	e9f30eb8a3915c3b2af009c832bff9b349b65ae5
ToppCell	BL-critical-LOC-Myeloid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MGAM NFKBIA LILRA5 DSE	1.84e-04	197	64	4	932a7fae4979b561688e6222505df0f4e510ab11
ToppCell	medial-2-Hematologic-Classical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VNN1 SIGLEC14 GAS7 LILRA5	1.84e-04	197	64	4	fbff79d6ece1605126ae0caa0c71253ea557779c
ToppCell	medial-Hematologic-Classical_Monocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VNN1 SIGLEC14 GAS7 LILRA5	1.84e-04	197	64	4	3960eac4b6753e3294e13901f6ea13d894275c8d
Drug	VAL-TRP	MGAM GANC STT3B	6.68e-07	7	62	3	CID000168182
Drug	tempo-maleimide	MGAM GANC SLC40A1	6.85e-06	14	62	3	CID002724304
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	LMF2 ANGPTL2 CLCA2 MMP27 GAS7 GRM2	1.69e-05	199	62	6	3625_UP
Drug	melezitose	MGAM GANC SLC40A1	2.12e-05	20	62	3	CID000092817
Drug	callyspongynic acid	MGAM GANC	2.18e-05	3	62	2	CID000636783
Drug	IPG7F	MGAM GANC	2.18e-05	3	62	2	CID003083273
Drug	Pradimicin Q	MGAM GANC	2.18e-05	3	62	2	CID000073572
Drug	7-deoxy-6-epi-castanospermine	MGAM GANC	2.18e-05	3	62	2	CID000125391
Drug	AC1NUR2V	MGAM GANC	2.18e-05	3	62	2	CID005489114
Drug	3-nitro-4-(6-aminohexylamido)phenylboronic acid	MGAM GANC	2.18e-05	3	62	2	CID000133488
Drug	3,3-Dimethyl-1,2-butanediol	MYO5A MYO5C	2.18e-05	3	62	2	CID000101077
Drug	myrciaphenone B	MGAM GANC	4.36e-05	4	62	2	CID000183139
Drug	glycovir	MGAM GANC	4.36e-05	4	62	2	CID000060807
Drug	thiochroman-4-one	MGAM GANC	4.36e-05	4	62	2	CID000019048
Drug	2-deoxymaltose	MGAM GANC	4.36e-05	4	62	2	CID003081508
Drug	AC1L3RZ0	MGAM GANC	4.36e-05	4	62	2	CID000145814
Drug	NSC277293	MGAM GANC	4.36e-05	4	62	2	CID000321973
Drug	gamma-glutamyl-2-naphthylamide	MGAM GANC	4.36e-05	4	62	2	CID000164706
Drug	5-norbornene-2,2-dimethanol	MYO5A MYO5C	4.36e-05	4	62	2	CID000110917
Drug	atalaphyllidine	MGAM GANC	4.36e-05	4	62	2	CID005479542
Drug	1,2-cyclopentanediol	MYO5A MYO5C	4.36e-05	4	62	2	CID000095497
Drug	AC1L970Z	MGAM GANC STT3B	6.68e-05	29	62	3	CID000439275
Drug	tetrachlorophthalimide	MGAM GANC	7.26e-05	5	62	2	CID000074077
Drug	(-)-Lentiginosine	MGAM GANC	7.26e-05	5	62	2	CID000130407
Drug	pinacol	MYO5A MYO5C	7.26e-05	5	62	2	CID000006425
Drug	D-gluco-octenitol	MGAM GANC	7.26e-05	5	62	2	CID006438548
Drug	beta-D-glucopyranosyl azide	MGAM GANC	7.26e-05	5	62	2	CID000152302
Drug	pulmatin	MGAM GANC	7.26e-05	5	62	2	CID000442731
Drug	Ro 22-0654	MGAM GANC	7.26e-05	5	62	2	CID000133753
Drug	AC1OCFTL	MGAM GANC	1.09e-04	6	62	2	CID006918743
Drug	conduritol aziridine	MGAM GANC	1.09e-04	6	62	2	CID000130051
Drug	AC1NSXES	MGAM GANC	1.09e-04	6	62	2	CID005318890
Drug	3KBG5CNP	MGAM GANC	1.52e-04	7	62	2	CID003083250
Drug	myrciacitrin I	MGAM GANC	1.52e-04	7	62	2	CID000183137
Drug	Mor-502	MGAM GANC	1.52e-04	7	62	2	CID003080955
Drug	ND2001	MGAM GANC	1.52e-04	7	62	2	CID000160207
Drug	sulcofuron	MYO5A MYO5C	1.52e-04	7	62	2	CID000062506
Drug	N-dodecylimidazole	MGAM GANC	1.52e-04	7	62	2	CID000078002
Drug	heptenitol	MGAM GANC	1.52e-04	7	62	2	CID000188267
Drug	isomaltotetraose	MGAM GANC	1.52e-04	7	62	2	CID003080783
Drug	desmanthin-1	MGAM GANC	1.52e-04	7	62	2	CID005316590
Drug	Aspartylglutamate	CRYGS GRM2 STT3B	1.77e-04	40	62	3	CID000151403
Drug	erythrose	CRYBA2 CRYBB2 CRYGS	1.77e-04	40	62	3	CID000094176
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A	DCHS2 ANGPTL2 CLCA2 VNN1 TENM1	1.82e-04	193	62	5	6730_UP
Drug	Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A	RELN LMF2 TENM4 GAS7 MMP11	1.91e-04	195	62	5	6465_UP
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A	HYAL4 TENM4 ANGPTL2 CLCA2 LILRA5	1.95e-04	196	62	5	6464_UP
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	ANGPTL2 OLFM4 GAS7 GRM2 MMP11	1.95e-04	196	62	5	4567_UP
Drug	indeloxazine	MGAM GANC	2.02e-04	8	62	2	CID000003704
Drug	9 mM of H	MGAM GANC	2.02e-04	8	62	2	CID000130464
Drug	3,4,5-triCQA	MGAM GANC	2.02e-04	8	62	2	CID006440783
Drug	NSC636590	MGAM GANC	2.02e-04	8	62	2	CID000072285
Drug	AC1L6VJ8	MGAM GANC	2.02e-04	8	62	2	CID000300088
Drug	casuarictin	MGAM GANC	2.02e-04	8	62	2	CID000073644
Drug	AC1NSUE6	MGAM GANC	2.02e-04	8	62	2	CID005316558
Drug	N-dodecyl morpholine	MGAM GANC	2.02e-04	8	62	2	CID000073764
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	LMF2 CLCA2 GAS7 MMP11 SEMA4G	2.05e-04	198	62	5	6925_UP
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	RELN CLCA2 GAS7 GRM2 MMP11	2.05e-04	198	62	5	5431_UP
Drug	(S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	HYAL4 RELN TENM4 ANGPTL2 SIGLEC5	2.05e-04	198	62	5	3523_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	DCHS2 CLCA2 GAS7 GRM2 TRIM22	2.10e-04	199	62	5	5280_UP
Drug	2-acetyl-1-pyrroline	MGAM DSE	2.59e-04	9	62	2	CID000522834
Drug	leucrose	MGAM GANC	2.59e-04	9	62	2	CID000165577
Drug	m265	MGAM GANC	2.59e-04	9	62	2	CID000074189
Drug	nectrisine	MGAM GANC	3.24e-04	10	62	2	CID000122106
Drug	AC1LCY75	MGAM GANC	3.24e-04	10	62	2	CID000639298
Drug	( )-Calystegine A3	MGAM GANC	3.24e-04	10	62	2	CID000183073
Drug	Glc)4	MGAM GANC	3.24e-04	10	62	2	CID000189098
Drug	Ro 20-0083	MGAM GANC	3.24e-04	10	62	2	CID003082332
Drug	AC1L3M0Q	MGAM GANC	3.24e-04	10	62	2	CID000118008
Drug	TAK-013	MGAM GANC	3.24e-04	10	62	2	CID003038517
Drug	desoxyrhaponticin	MGAM GANC	3.24e-04	10	62	2	CID004430533
Drug	trehazolin	MGAM GANC	3.24e-04	10	62	2	CID003081797
Drug	imazaquin	MYO5A MYO5C	3.24e-04	10	62	2	CID000054739
Drug	etridiazole	MYO5A STT3B MYO5C	3.44e-04	50	62	3	CID000017432
Drug	formycin triphosphate	MGAM MYO5A MYO5C	3.65e-04	51	62	3	CID000122274
Drug	T1 p	CRYBA2 CRYBB2 CRYGS	3.65e-04	51	62	3	CID000657023
Drug	H S Q	HYAL4 SLC6A7 MGAM SIGLEC5 MMP11 STT3B	3.82e-04	351	62	6	CID000000897
Drug	glucosyl fluoride	MGAM GANC	3.95e-04	11	62	2	CID000150967
Drug	CNP-G5	MGAM GANC	3.95e-04	11	62	2	CID000127309
Drug	galactosylarabinose	MGAM GANC	3.95e-04	11	62	2	CID000193417
Drug	IQ-3	MYO5A MYO5C	3.95e-04	11	62	2	CID000028212
Drug	trehalulose	MGAM GANC	3.95e-04	11	62	2	CID000162104
Drug	AC1NUSO2	MGAM GANC	3.95e-04	11	62	2	CID005460006
Disease	hereditary spastic paraplegia 3A (implicated_via_orthology)	ATL3 ATL2 ATL1	7.59e-09	3	59	3	DOID:0110791 (implicated_via_orthology)
Disease	Cataract, Central Saccular, With Sutural Opacities	CRYBB2 CRYGS	5.87e-05	6	59	2	C1854021
Disease	hereditary spastic paraplegia (implicated_via_orthology)	ATL3 ATL2 ATL1	8.85e-05	43	59	3	DOID:2476 (implicated_via_orthology)
Disease	Hereditary Sensory Autonomic Neuropathy, Type 1	ATL3 ATL1	1.09e-04	8	59	2	C0020071
Disease	dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement	SIGLEC14 SIGLEC5	1.75e-04	10	59	2	EFO_0801544
Disease	Psoriasis	VNN1 NFKBIA ZC3H12C	2.06e-04	57	59	3	C0033860
Disease	Pustulosis of Palms and Soles	VNN1 NFKBIA ZC3H12C	2.06e-04	57	59	3	C0030246
Disease	sialic acid-binding Ig-like lectin 14 measurement	SIGLEC14 SIGLEC5	2.56e-04	12	59	2	EFO_0008284
Disease	DNA methylation	DCHS2 TENM4 ABCA13 HYAL1 MIPEP USH2A ADCYAP1R1	3.26e-04	656	59	7	GO_0006306
Disease	mitochondrial heteroplasmy measurement	SLC6A7 MGAM LMF2	3.62e-04	69	59	3	EFO_0600008
Disease	teratocarcinoma-derived growth factor 1 measurement	MYO5A GAS7	4.63e-04	16	59	2	EFO_0008297
Disease	Nuclear cataract	CRYBA2 CRYBB2	5.89e-04	18	59	2	C0392557
Disease	Nuclear non-senile cataract	CRYBA2 CRYBB2	5.89e-04	18	59	2	C1112705
Disease	nucleus accumbens volume	USH2A STT3B	8.85e-04	22	59	2	EFO_0006931
Disease	Hodgkin Disease	RELN NFKBIA	8.85e-04	22	59	2	C0019829
Disease	progression free survival, ovarian serous carcinoma	MGAM ABCA13	8.85e-04	22	59	2	EFO_0004920, EFO_1001516
Disease	bone fracture	TPCN2 SLC40A1 AXIN1	1.48e-03	112	59	3	EFO_0003931
Disease	1,5 anhydroglucitol measurement	MGAM MGAM2	1.54e-03	29	59	2	EFO_0008009

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQSGTWVGYQYPGYR	CRYBB2	146	P43320
AGSGRYRYQKVGYWA	GRM2	461	Q14416
SSGAWVAYQYPGYRG	CRYBA2	146	P53672
DWRQYGITLYSHPYG	ABCA13	4426	Q86UQ4
VWYRGGHYRSRYQDG	ANGPTL2	451	Q9UKU9
WRGYQTERGVYGYRP	DHTKD1	21	Q96HY7
YGQEIWSREPYYARP	CPXM2	36	Q8N436
VGQYGYTLPGWRKYN	MMP27	96	Q9H306
AGRYRCYYYSPAGWS	LILRA5	111	A6NI73
PYWALGFHLSRYGYQ	MGAM2	1196	Q2M2H8
GQWGYHCYEPRIYRS	ASB17	36	Q8WXJ9
YFPRARWYDYYTGVD	MGAM	1676	O43451
RWYDYYTGVDINARG	MGAM	1681	O43451
AYFPRARWYDYYTGV	MGAM	2571	O43451
RWYQAGAYQPFFRGH	GANC	631	Q8TET4
GYMYETSYRRGWGFQ	DSE	186	Q9UL01
VTYQGYSPYQLTWGR	NFKBIA	246	P25963
FSYTEPNYWIRYGGR	P3H2	391	Q8IVL5
YYYARGDHWPFSTVL	P2RY2	91	P41231
PERRYFYWYTIIGWG	ADCYAP1R1	261	P41586
GSVRFRWYQGFYPAG	RELN	2101	P78509
RPYTGWIYLRRQFDY	DCHS2	1136	Q6V1P9
IRTGYRPTGHEWRYY	PAQR8	51	Q8TEZ7
RPTGHEWRYYFFSLF	PAQR8	56	Q8TEZ7
WAYIRYSGEYRELGA	ATL1	491	Q8WXF7
GGVQFEIWCRYYYPN	C2CD3	1106	Q4AC94
VWIFYELPNYRGRQY	CRYGS	136	P22914
RLSNIERNWPYYFGF	EI24	231	O14681
YSEGREFRYGSWREP	AXIN1	286	O15169
EFRYGSWREPVNPYY	AXIN1	291	O15169
NVTIFYVNRLGYYPW	HYAL4	86	Q2M3T9
FLIRDWSYPYEHSYG	ATL2	241	Q8NHH9
LVRDWSFPYEYSYGL	ATL3	211	Q6DD88
TWGYIRYSGQYRELG	ATL3	486	Q6DD88
HAFYYSWYGSPRREG	MANEAL	106	Q5VSG8
RGLWGFYGFPDCYNY	HYAL1	196	Q12794
LQYNYTFWYSRRTPG	EIF4E2	56	O60573
RRWSYRCYGYDSRAP	LILRA3	191	Q8N6C8
YFFRGRDYWRFHPST	MMP11	401	P24347
TYEYRISAWNSYGRG	USH2A	3471	O75445
YVRAQRYKYWFSQPG	LMF2	556	Q9BU23
PGWQSYLSPQGRRYY	GAS7	81	O60861
YSSPPLYVYWFRDGE	SIGLEC5	51	O15389
ASGWTVQYYYDGLGR	TENM1	2241	Q9UKZ4
PFRTFRDGWVSYYNQ	SLC40A1	291	Q9NP59
FNSYGLWGRLSLGYY	SLC25A53	161	Q5H9E4
GFSYLYGAWGRDYSP	OLFM4	266	Q6UX06
WRFPYRAYTNGGGAF	SLC6A7	61	Q99884
WYGAHGDDPYTLQYR	CLCA2	116	Q9UQC9
PDVYTYLGIYRANRW	C11orf68	246	Q9H3H3
AIYGWNFNRDSLYPY	VNN1	81	O95497
PYMEYQDGSRRWGRY	SEMA4G	351	Q9NTN9
WDPPYYSGVIRAERY	MIPEP	356	Q99797
RGYAGYFDLWPYRAP	RBMXL3	131	Q8N7X1
GAEFQGRRYRWLPYY	PAPLN	96	O95428
LTYTGYIAPWSGRFY	STT3B	371	Q8TCJ2
YFSRAGFPSWQYQRL	SPDYE1	191	Q8NFV5
YSGSPELFWYVQYSR	TRAV16	46	A0A0A6YYK6
YNRAGSWSVRYRYDG	TENM4	2281	Q6N022
PRAYSYWVRYQGPYV	TAS1R2	666	Q8TE23
SWERPGYGIDAYGYR	ZC3H12C	776	Q9C0D7
KVYSRYRPQYGYWVI	TRIM22	396	Q8IYM9
YSSPPLYVYWFRDGE	SIGLEC14	51	Q08ET2
AYRRYSGPWSKIYFV	TPCN2	661	Q8NHX9
AYSRYQPQSGYWVIG	TRIM6	391	Q9C030
GYTGARNYAGAYREW	TSTD1	96	Q8NFU3
VRIYHDRWGYGVYSG	MYMK	106	A6NI61
GFPSRWTYQEFFSRY	MYO5A	696	Q9Y4I1
YPSRWTYIEFYSRYG	MYO5C	686	Q9NQX4